ENVALITH
ダイキョーニシカワ株式会社 logo

DaikyoNishikawa Corporation

4246Prime MarketChemicals

ダイキョーニシカワ株式会社 logo
DaikyoNishikawa Corporation4246
Reference Indicators

Market Cap

712¥100M

P/E (Forecast)

P/B

0.7x

Dividend Yield (Forecast)

5.68%

ROE

9.8%

EV/EBITDA

3.1x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
116,669145,744159,019168,561165,706
Cost of Sales
108,934131,955138,550146,186143,043
Gross Profit
7,73513,78920,46922,37522,662
SG&A Expenses
10,36810,33511,77812,37012,411
Operating Income
-2,6323,4538,69010,00410,251
Non-operating Income
2,1918071,6342,3911,459
Non-operating Expenses
5441,3961,5482,7071,000
Ordinary Income
-9852,8648,7759,68810,709
Extraordinary Income
1,277191,851104
Extraordinary Losses
1,2013682,371155158
Pre-tax Income
-9092,5158,2559,54310,556
Income Taxes
1,2741,9752,8722,9641,661
Net Income
-2,0855185,7826,4988,661
EBITDA
8,16615,34820,31521,00221,013
Gross Margin
6.6%9.5%12.9%13.3%13.7%
Operating Margin
-2.3%2.4%5.5%5.9%6.2%
ROA
-1.3%0.3%3.6%4.2%5.5%
ROE
-2.8%0.7%7.4%7.7%9.8%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
日本101,3053,4293.4%
北米46,8595,60712.0%
アセアン10,8785465.0%
中国・韓国6,663771.2%